Gemtesa 75 MG tablet 90S
Ended Awarded
- Contract number
- SPE2DB25FMUAQ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,845
Award facts
- Contract value 100% obligated
- $17,844.91 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $17,844.91 to AmerisourceBergen Drug Corp for the supply of Gemtesa 75 mg tablets (90-count units) on June 25, 2025, with an ultimate completion date of June 26, 2025. This firm fixed-price delivery order is unclassified as a set-aside contract and represents a competitive award to the prime contractor. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract under a larger vehicle, this delivery order falls under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support agreement valued at $999,999,999.00 and extending through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company maintains an extensive portfolio of pharmaceutical deliveries through its DLA contracts, encompassing brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This delivery order for Gemtesa, a urological medication, exemplifies the company's role in supplying specialized pharmaceutical products to support Defense Health Agency operations and other federal healthcare systems. All of AmerisourceBergen's reviewed contract awards have been competitively awarded without set-aside designations, demonstrating the company's capability to meet federal procurement requirements in open competition.
Quick answers
Who was awarded contract SPE2DB25FMUAQ?
SPE2DB25FMUAQ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 25, 2025.
How much is contract SPE2DB25FMUAQ worth?
The government has obligated $17,845 on SPE2DB25FMUAQ.
Is contract SPE2DB25FMUAQ an order under another contract?
Yes. SPE2DB25FMUAQ is a delivery order under SPE2DB20D2104, an indefinite delivery contract.
Was contract SPE2DB25FMUAQ competed?
The extent of competition for SPE2DB25FMUAQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award